Article Details

JP Morgan restarts AstraZeneca at overweight, sees re-rating opportunity

Retrieved on: 2021-08-12 14:37:30

Tags for this article:

Click the tags to see associated articles and topics

JP Morgan restarts AstraZeneca at overweight, sees re-rating opportunity. View article details on hiswai:

Excerpt

Analysts at JP Morgan resumed their coverage of AstraZeneca at 'overweight', telling clients they saw a "re-rating opportunity". Advertising ...

Article found on: www.sharecast.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up